Species and gender differences affect the metabolism of emodin via glucuronidation.
The aim of the present study was to define the mechanisms responsible for poor bioavailability of emodin by determining its metabolism using in vitro and in situ disposition models of the intestine and liver. Liver microsomes of mice, rats, guinea pigs, dogs, and humans were used along with the rat intestinal perfusion model and the rat intestinal microsomes. In the rat intestine, excretion rates of emodin-3-O-glucuronide were significantly different (p < 0.05) in four regions of the intestine and were higher in males than in females (p < 0.01). Emodin glucuronidation in liver microsomes was species-dependent, and K (m) values varied 5.7-fold (3.2-18.2 microM) in males and 2.8-fold (4.6-13.0 microM) in females. The male intrinsic clearance (CL(int)) values differed by 5-fold (27.6-138.3 mL h(-1) mg(-1) protein), and female CL(int) values differed by 4.3-fold (24.3-103.5 mL h(-1) mg(-1) protein). Since CL(int) values of emodin glucuronidation were 10-fold higher than that of isoflavones, emodin was considered rapidly glucuronidated. In contrast to the large species-dependent effects on K (m) and CL(int) values, gender had a smaller effect on these kinetic parameters (2-fold, p < 0.05). Lastly, glucuronidation rates obtained using liver microsomes from various experimental animals of the same gender correlated well with those in human liver microsomes. In conclusion, Rapid metabolism by UDP-glucuronosyltransferase is the major reason why emodin has poor bioavailability. Species and gender affected emodin metabolism to a different degree, and experimental animals are expected to be useful in predicting emodin glucuronidation in humans.
Liu
Wei
W
Department of Pharmaceutics, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, Guangdong 510515, China.
Tang
Lan
L
Ye
Ling
L
Cai
Zheng
Z
Xia
Bijun
B
Zhang
Jiajie
J
Hu
Ming
M
Liu
Zhongqiu
Z
D000818:Animals; D001682:Biological Availability; D002400:Cathartics / Q000493:pharmacokinetics*; D002853:Chromatography, Liquid; D004642:Emodin / Q000493:pharmacokinetics*; D005260:Female; D020719:Glucuronides / Q000378:metabolism*; D006801:Humans; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D012737:Sex Factors; D013045:Species Specificity; D053719:Tandem Mass Spectrometry
D002400:Cathartics; D020719:Glucuronides; D004642:Emodin
Antioxid Redox Signal. 2005 Nov-Dec;7(11-12):1630-47
16356126
Drug Metab Dispos. 2000 Mar;28(3):246-54
10681367
Mutat Res. 1984 Feb;125(2):135-44
6366529
Cancer Biol Ther. 2008 Mar;7(3):468-75
18285700
Xenobiotica. 1981 Mar;11(3):217-25
7293218
Toxicol Appl Pharmacol. 2000 Apr 15;164(2):206-15
10764634
Semin Oncol. 2001 Dec;28(6 Suppl 18):21-9
11774202
Drug Metab Dispos. 2005 Dec;33(12):1777-84
16120792
Drug Metab Dispos. 2003 Jul;31(7):924-31
12814970
Cancer Res. 2004 Jan 1;64(1):108-16
14729614
Biosci Biotechnol Biochem. 2007 Jul;71(7):1636-43
17617731
Drug Metab Dispos. 2006 Nov;34(11):1837-48
16882763
Eur J Pharmacol. 2003 Jul 25;473(2-3):117-25
12892828
Cell Mol Life Sci. 2005 May;62(10):1167-75
15928809
Food Chem Toxicol. 2008 Feb;46(2):733-9
17981383
Pharm Res. 1988 Oct;5(10):651-4
3244618
Anesth Analg. 1995 Oct;81(4):855-61
7574023
Mutat Res. 1988 Feb;204(2):329-32
3343982
Med Res Rev. 2007 Sep;27(5):591-608
17019678
Biochem Pharmacol. 2004 Jul 15;68(2):361-71
15194008
J Theor Biol. 1988 Mar 7;131(1):107-14
3419188
Cancer Res. 2005 Mar 15;65(6):2287-95
15781642
Biochem Pharmacol. 2005 Jul 15;70(2):229-41
15941563
Drug Metab Dispos. 2009 Apr;37(4):834-40
19131521
Mutat Res. 1985 May;149(3):327-32
3887143
J Agric Food Chem. 2003 Jan 29;51(3):571-81
12537425
Biomed Chromatogr. 2008 Nov;22(11):1230-6
18651591
J Pharm Sci. 2010 Apr;99(4):2185-95
19921750
Biochem Biophys Res Commun. 2004 Dec 10;325(2):549-54
15530427
Drug Metab Dispos. 2002 Apr;30(4):355-62
11901086
J Pharmacol Exp Ther. 2009 Jun;329(3):1023-31
19264971
Eur J Pharmacol. 1992 Feb 18;211(3):359-64
1535596
Mol Pharm. 2009 Sep-Oct;6(5):1466-82
19545173
Mutat Res. 1996 Dec 20;371(3-4):165-73
9008718
Med Res Rev. 2007 Sep;27(5):609-30
17022020
J Pharm Sci. 1998 Jul;87(7):886-90
9649359
Mutat Res. 1992 May 1;279(1):1-8
1374527
Chem Biol Drug Des. 2008 May;71(5):474-482
18384527